Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (441-450 of 752) with videos related to

Pageof 76
Sort By:
Blood|July 2, 2002
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophilsJohann Wojta, Christoph Kaun, Gerlinde Zorn, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 9, 2024
Diabetes mellitus and presentation, care and outcomes of patients with NSTEMI: the Association for Acute Cardiovascular Care-European Association of Percutaneous Cardiovascular Interventions EURObservational Research Programme NSTEMI Registry of the European Society of CardiologyRamesh Nadarajah, Peter Ludman, Cécile Laroche, et al.
Journal of Personalized Medicine|February 25, 2023
Peri-Interventional Triple Therapy with Dabigatran Modifies Vasomotion after Bare-Metal Stent Implantation in a Pig Coronary Artery ModelRayyan Hemetsberger, Serdar Farhan, Dominika Lukovic, et al.
Journal of Molecular and Cellular Cardiology|April 15, 2004
Prostaglandin E1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanismThomas Werner Weiss, Mohammad Reza Mehrabi, Christoph Kaun, et al.
European Journal of Clinical Investigation|March 3, 2021
Mid-regional pro-atrial natriuretic peptide independently predicts short-term mortality in COVID-19Christoph C Kaufmann, Amro Ahmed, Mona Kassem, et al.
Frontiers in Cardiovascular Medicine|July 26, 2021
Peri-interventional Triple Therapy With Dabigatran Improves Vasomotion and Promotes Endothelialization in Porcine Coronary Stenting ModelRayyan Hemetsberger, Serdar Farhan, Dominika Lukovic, et al.
Journal of Molecular and Cellular Cardiology|July 8, 2014
Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiencesNoemi Pavo, Silvia Charwat, Noemi Nyolczas, et al.
Journal of Clinical Medicine|July 1, 2020
Prognostic Impact of Active Mechanical Circulatory Support in Cardiogenic Shock Complicating Acute Myocardial Infarction, Results from the Culprit-Shock TrialHans-Josef Feistritzer, Steffen Desch, Anne Freund, et al.
Wiener Klinische Wochenschrift|August 21, 2014
Dabigatran: patient management in specific clinical settingsPaul Alexander Kyrle, Konrad Binder, Sabine Eichinger, et al.
Circulation. Cardiovascular Interventions|November 30, 2012
B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trialRudolf Jarai, George Dangas, Kurt Huber, et al.
Pageof 76

Showing results (441-450 of 752) with videos related to

Sort By:
Pageof 76
Blood|July 2, 2002
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophilsJohann Wojta, Christoph Kaun, Gerlinde Zorn, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 9, 2024
Diabetes mellitus and presentation, care and outcomes of patients with NSTEMI: the Association for Acute Cardiovascular Care-European Association of Percutaneous Cardiovascular Interventions EURObservational Research Programme NSTEMI Registry of the European Society of CardiologyRamesh Nadarajah, Peter Ludman, Cécile Laroche, et al.
Journal of Personalized Medicine|February 25, 2023
Peri-Interventional Triple Therapy with Dabigatran Modifies Vasomotion after Bare-Metal Stent Implantation in a Pig Coronary Artery ModelRayyan Hemetsberger, Serdar Farhan, Dominika Lukovic, et al.
Journal of Molecular and Cellular Cardiology|April 15, 2004
Prostaglandin E1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanismThomas Werner Weiss, Mohammad Reza Mehrabi, Christoph Kaun, et al.
European Journal of Clinical Investigation|March 3, 2021
Mid-regional pro-atrial natriuretic peptide independently predicts short-term mortality in COVID-19Christoph C Kaufmann, Amro Ahmed, Mona Kassem, et al.
Frontiers in Cardiovascular Medicine|July 26, 2021
Peri-interventional Triple Therapy With Dabigatran Improves Vasomotion and Promotes Endothelialization in Porcine Coronary Stenting ModelRayyan Hemetsberger, Serdar Farhan, Dominika Lukovic, et al.
Journal of Molecular and Cellular Cardiology|July 8, 2014
Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiencesNoemi Pavo, Silvia Charwat, Noemi Nyolczas, et al.
Journal of Clinical Medicine|July 1, 2020
Prognostic Impact of Active Mechanical Circulatory Support in Cardiogenic Shock Complicating Acute Myocardial Infarction, Results from the Culprit-Shock TrialHans-Josef Feistritzer, Steffen Desch, Anne Freund, et al.
Wiener Klinische Wochenschrift|August 21, 2014
Dabigatran: patient management in specific clinical settingsPaul Alexander Kyrle, Konrad Binder, Sabine Eichinger, et al.
Circulation. Cardiovascular Interventions|November 30, 2012
B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trialRudolf Jarai, George Dangas, Kurt Huber, et al.
Pageof 76